[Sephiroth]

§5.4 could make things awkward for the UK because AZ signed up to the definition in Schedule A.

5.4. Manufacturing Sites. AstraZeneca shall use its Best Reasonable Efforts to
manufacture the Vaccine at manufacturing sites located within the EU (which, for the
purpose of this Section 5.4 only shall include the United Kingdom) and may manufacture the Vaccine in non-EU facilities, if appropriate, to accelerate supply of the Vaccine in Europe; provided, that AstraZeneca shall provide prior written notice of such non-EU manufacturing facilities to the Commission which shall include an explanation for such determination to use non-EU manufacturing facilities. If AstraZeneca is unable to deliver on its intention to manufacture the Initial Europe Doses and/or Optional Doses under this Agreement in the EU, the Commission or the Participating Member States may present to AstraZeneca, CMOs within the EU capable of manufacturing the Vaccine Doses, and AstraZeneca shall use its Best Reasonable Efforts to contract with such proposed CMOs to increase the available manufacturing capacity within the EU. The manufacturing site planning is set out in Schedule A.

However, the bit highlighted in purple suggests a different approach from legal action that would let the UK manufacturing off the hook.